Fever of Unknown Cause: A Case of Macrophage Activation Syndrome
Macrophage Activation Syndrome
DOI:
https://doi.org/10.5281/zenodo.15569678Keywords:
Fever of Unknown Origin, Macrophage Activation Syndrome, ChildAbstract
Fever of unknown origin (FUO) in children is a challenging diagnostic problem, as it can be caused by a wide range of infectious, inflammatory, malignant, or genetic disorders. We present the case of a 12-year-old girl with persistent fever, arthralgia, and elevated inflammatory markers. Despite extensive infectious, oncological, and rheumatologic investigations, no underlying cause was identified. Laboratory findings revealed markedly increased C-reactive protein, ferritin, and D-dimer levels, and mild hepatomegaly. Macrophage activation syndrome (MAS) was suspected due to persistent fever and hyperferritinemia, and confirmed by bone marrow aspiration. The patient responded rapidly to intravenous immunoglobulin and high-dose corticosteroids. This case emphasizes the importance of considering MAS in pediatric FUO and highlights the need for early recognition and treatment.
References
PETERSDORF RG, BEESON PB. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore). 1961;40:1-30. doi:10.1097/00005792-196102000-00001
Durack DT, Street AC. Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35-51.
Cunha BA. Fever of unknown origin: clinical overview of classic and current concepts [published correction appears in Infect Dis Clin North Am. 2008 Jun;22(2):xv]. Infect Dis Clin North Am. 2007;21(4):867-vii. doi:10.1016/j.idc.2007.09.002
Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of unknown origin: an evidence-based review. Am J Med Sci. 2012;344(4):307-316. doi:10.1097/MAJ.0b013e31824ae504
Wakai S, Murayama S, Gomi H. Diagnostic strategy for pediatric fever of unknown origin. Pediatr Int. 2022;64(1):e14911.2
Ravelli A, Minoia F, Davi S, et al. Macrophage activation syndrome. Nat Rev Rheumatol. 2012;8(5):301-309.
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. 2016;12(5):259-268. doi:10.1038/nrrheum.2015.179
Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome. Rheum Dis Clin North Am. 2015;41(4):537-546.
Grom AA, Jordan MB, Newburger PE, et al. Macrophage activation syndrome in the setting of pediatric rheumatologic disease. Arthritis Rheum. 2003;48(3):771-781
Schulert GS, Grom AA, Rosenbaum JT. Macrophage activation syndrome: a hemophagocytic syndrome associated with rheumatic diseases. J Rheumatol. 2014;41(6):1041-1048.
Yao TC, Lee JH, Yeh KW, et al. Treatment of macrophage activation syndrome in children with systemic juvenile idiopathic arthritis. Semin Arthritis Rheum. 2015;45(2):188-195.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Pelin Arslan, Gürkan Karakuş
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0)
